CAR Therapy for Solid Tumors Draws Attention at Annual Cancer Conference
June 18th 2019Results from a clinical trial in people with mesothelioma indicate that an experimental chimeric antigen receptor-T cell therapy is safe and may provide benefit to patients, especially in combination with other immunotherapies.
Read More